Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) currently has a daily average trading volume of 1.26M but it saw 1117781 shares traded in last market. With a market cap of 3.08B USD, the company’s current market price of $25.29 came rising about 1.53 while comparing to the previous closing price of $24.91. In past 52 weeks, the stock remained buoying in the range of price level as high as $26.16 and as low as $14.75. In the recent trading on the day, stock has struck highest price mark of $24.8 while lowest mark touched by it was $25.55.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Robert W. Baird which initiated the stock as “Outperform” in its note to investors issued on February 04, 2025, recommending a price target of $28 for it. Citigroup also issued its recommendations for the stock as it initiated the price target for the stock is $27.
Over the week, CPRX’s stock price is moving 3.06% up while it is 4.07% when we observe its performance for the past one month. Year-to-date it is 21.18% up and over the past year, the stock is showing an upside performance of 56.40%.
Currently, Catalyst Pharmaceuticals Inc’s total number of outstanding shares is 121.96M with 6.22% of that held by the insiders while 83.37% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 24.76% and return on equity (ROE) at 29.11%. It has a price to earnings ratio (P/E ratio) of 16.14 while having a 13.94 of forward P/E ratio. Stock’s beta reads 0.72. Stock has a price to book (P/B) ratio of 3.88 while price to sale or P/S ratio amounts to 5.77. Its return on asset (ROA) is 25.37% on average.
